News|Articles|April 15, 2014
- Pharmaceutical Technology-04-15-2014
- Volume 2014 eBook
- Issue 1
A Quality-by-Design Approach to Optimize In-Process Curing of EUDRAGIT NM 30 D
Author(s)Sascha Jautze
A study investigated the influence and correlation of critical process parameters for the optimization of in-process curing.
Advertisement
Previous studies with EUDRAGIT NM 30 D showed that storage stability can be achieved with in-process curing at specific conditions. The aim of this study was to identify and investigate the influence and correlation of critical process parameters for the optimization of in-process curing.
Download
.
Articles in this issue
over 11 years ago
Continuous Manufacturing for Solid-Dosage Drug Productionover 11 years ago
Using Modular Systems in Solid-Dosage Manufacturingover 11 years ago
Advances in Hot-Melt Extrusion Manufacturingover 11 years ago
Selection of Excipients in Generic FormulationsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
5
